Stocks and Investing Stocks and Investing
Fri, May 15, 2020
Thu, May 14, 2020

Mani Foroohar Reiterated (BBIO) at Buy with Decreased Target to $39 on, May 14th, 2020


Published on 2024-10-27 06:26:15 - WOPRAI, Mani Foroohar
  Print publication without navigation


Mani Foroohar of SVB Leerink, Reiterated "BridgeBio Pharma, Inc." (BBIO) at Buy with Decreased Target from $41 to $39 on, May 14th, 2020.

Mani has made no other calls on BBIO in the last 4 months.



There are 3 other peers that have a rating on BBIO. Out of the 3 peers that are also analyzing BBIO, 0 agree with Mani's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Mani


  • Raghuram Selvaraju of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $50 on, Monday, April 13th, 2020
  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $43 on, Tuesday, March 3rd, 2020
  • Salim Syed of "Mizuho" Initiated at Strong Buy and Held Target at $51 on, Wednesday, February 19th, 2020
Contributing Sources